Ubrelvy – Talk Bio

Actionable Insights Powered by AI

FDA Criticizes AbbVie for Misleading Ad Featuring Serena Williams Promoting Migraine Drug Ubrelvy

7 months ago talkbio0Tagged AbbVie, Advertising (activity), Migraine Disorders, misleading, Serena, Ubrelvy, United States Food and Drug Administration, Williams

FDA, AbbVie, Serena Williams, Ubrelvy, Migraine Drug, Misleading Advertising